» Articles » PMID: 31931514

Key Barriers and Enablers Associated with Uptake and Continuation of Oral Pre-exposure Prophylaxis (PrEP) in the Public Sector in Zimbabwe: Qualitative Perspectives of General Population Clients at High Risk for HIV

Overview
Journal PLoS One
Date 2020 Jan 14
PMID 31931514
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Understanding the perspectives and preferences of clients eligible for pre-exposure prophylaxis (PrEP) is essential to designing programs that meet clients' needs. To date, most PrEP programs in limited-resource settings have been implemented by partner organizations for specific target populations, but the government of Zimbabwe aims to make PrEP available to the broader population at substantial risk in public sector clinics. However, there is limited information on general population perspectives about PrEP in Zimbabwe.

Methods: A qualitative study was conducted to explore clients' motivation to take or decline PrEP and continue or discontinue PrEP. Through a PrEP pilot in one urban family planning clinic and one rural youth center in Zimbabwe, 150 HIV-negative clients screened as being at high risk of HIV and were offered PrEP between January and June 2018. Sixty semi-structured interviews were conducted with clients who agreed to follow-up (including 5 decliners, all from the rural youth center, and 55 accepters, with 42 from the rural youth center and 13 from the urban family planning clinic). Interviews were conducted after either the first or second PrEP follow-up appointment or after the client declined PrEP. Interviews were audio recorded, de-identified, transcribed, and coded thematically.

Results: PrEP uptake was driven by risk perception for HIV, and in many cases, that risk was introduced by the unsafe behavior or HIV-positive status of a partner. Among sero-discordant couples (SDCs), the desire to safely conceive a child was also cited as a factor in taking PrEP. Clients who opted for PrEP preferred it to other forms of HIV prevention. SDCs reported decreased condom use after PrEP initiation and in some cases were using PrEP while trying to conceive a child. After initiating PrEP, clients had more confidence in their sexual relationships and less stress associated with negotiating condom use. Family and partner support was critical to starting and continuing PrEP, but some clients stopped PrEP or missed appointments due to side effects or logistical challenges such as transportation.

Conclusions: Results of this study can be used to provide operational guidance for national public sector roll-out of PrEP as part of combination HIV prevention in Zimbabwe. Based on feedback and experiences of clients, the training materials for health workers can be refined to ensure that health workers are prepared to counsel clients on the decision to start and/or continue PrEP and answer common client questions. Program advertisements should also be targeted with key messages that speak to client experiences.

Trial Registration: Clinical Trial Registry Number: PACTR201710002651160.

Citing Articles

Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development.

Friedland B, Gundacker H, Achilles S, Chen B, Hoesley C, Richardson B PLoS One. 2025; 20(1):e0312957.

PMID: 39808648 PMC: 11731730. DOI: 10.1371/journal.pone.0312957.


"They are not HIV treatments drugs; they are preventive drugs (PrEP)". Experiences of PrEP uptake among vulnerable adolescent girls and young women in Tanzania.

Mwakilasa M, Mwijage A, Mushy S, Amour M, Sirili N, Maziku E PLoS One. 2025; 20(1):e0313501.

PMID: 39774510 PMC: 11709303. DOI: 10.1371/journal.pone.0313501.


HIV Prevention Product Acceptability and Preference Among Women in Sub-Saharan Africa to Inform Novel Biomedical Options in Development: A Systematic Review.

Makoni W, Lorenzetti L, Mancuso N, Luecke E, Dinh N, Deshpande A AIDS Behav. 2024; 29(1):257-293.

PMID: 39422786 DOI: 10.1007/s10461-024-04529-2.


Examining concordance of sexual-related factors and PrEP eligibility with HIV risk perception among adolescent girls and young women: cross-sectional insights from DREAMS sites in Kenya, Malawi, and Zambia.

Heck C, Reed D, Okal J, Chipeta E, Mbizvo M, Mathur S BMC Public Health. 2024; 24(1):2793.

PMID: 39395932 PMC: 11470662. DOI: 10.1186/s12889-024-20276-4.


PrEP discontinuation, cycling, and risk: Understanding the dynamic nature of PrEP use among female sex workers in South Africa.

Shipp L, Ryan S, Comins C, Mcingana M, Mulumba N, Guddera V PLoS One. 2024; 19(9):e0310489.

PMID: 39325776 PMC: 11426525. DOI: 10.1371/journal.pone.0310489.


References
1.
Thigpen M, Kebaabetswe P, Paxton L, Smith D, Rose C, Segolodi T . Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012; 367(5):423-34. DOI: 10.1056/NEJMoa1110711. View

2.
Dunkle K, Stephenson R, Karita E, Chomba E, Kayitenkore K, Vwalika C . New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet. 2008; 371(9631):2183-91. DOI: 10.1016/S0140-6736(08)60953-8. View

3.
Wamoyi J, Wight D, Plummer M, Mshana G, Ross D . Transactional sex amongst young people in rural northern Tanzania: an ethnography of young women's motivations and negotiation. Reprod Health. 2010; 7:2. PMC: 2867784. DOI: 10.1186/1742-4755-7-2. View

4.
Van der Elst E, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P . High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2012; 17(6):2162-72. PMC: 3690654. DOI: 10.1007/s10461-012-0317-8. View

5.
Pulerwitz J, Gortmaker S . Extrarelational sex among Mexican men and their partners' risk of HIV and other sexually transmitted diseases. Am J Public Health. 2001; 91(10):1650-2. PMC: 1446848. DOI: 10.2105/ajph.91.10.1650. View